San Diego Business Journal

Cypher Genomics, Sequenom to Partner on Developing Prenatal Tests

By Brittany Meiling Friday, January 23, 2015
   

Two San Diego companies, Cypher Genomics Inc. and Sequenom Inc., announced an agreement to further develop next-generation noninvasive prenatal tests.

Through this agreement, Sequenom, a molecular diagnostics company, will use Cypher's genome interpretation technology, Mantis, to advance analysis of fetal sub-chromosomal variants detected in maternal blood. Often not detected until after birth, sub-chromosomal variants are associated with significant risks of morbidity and mortality.